phenylephrine has been researched along with Benign Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arambasic, M; Caso, S; Cotecchia, S; Diviani, D; Maric, D | 1 |
| Bertolini, GL; Biazi, GR; de Fatima Silva, F; de Morais, H; de Souza, HM; Frasson, IG; Miksza, DR | 1 |
| Beer-Hammer, S; Bucher, K; Gollasch, M; Harteneck, C; Hirsch, E; Huang, Y; Nürnberg, B; Piekorz, R; Shymanets, A; Tsvetkov, D | 1 |
| PUZHAKA, KhIa | 1 |
| Ferrara, A; Fusi, F; Molnar, J; Saponara, S; Sgaragli, G; Zalatnai, A | 1 |
| Beckett, AH; Frohn, MJ; Jones, GR | 1 |
| Debreczeni, LA; Farsang, C; Takács, L | 1 |
| Hirst, DG; Keilty, G; Murray, M; O'Rourke, M; Robson, T; Worthington, J | 1 |
8 other study(ies) available for phenylephrine and Benign Neoplasms
| Article | Year |
|---|---|
AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
Topics: A Kinase Anchor Proteins; Adrenergic alpha-1 Receptor Agonists; Apoptosis; Doxorubicin; Gene Expression Regulation; HEK293 Cells; Humans; Lentivirus; Minor Histocompatibility Antigens; Myocytes, Cardiac; Neoplasms; Phenylephrine; Proto-Oncogene Proteins; Signal Transduction | 2017 |
Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor-bearing rats.
Topics: Adenosine Triphosphate; Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cachexia; Cyclic AMP; Glucagon; Gluconeogenesis; Glycogenolysis; Glycolysis; Isoproterenol; Liver; Male; Neoplasms; Perfusion; Phenylephrine; Rats; Rats, Wistar | 2018 |
Better Understanding of Phosphoinositide 3-Kinase (PI3K) Pathways in Vasculature: Towards Precision Therapy Targeting Angiogenesis and Tumor Blood Supply.
Topics: Androstadienes; Animals; Chromones; Class I Phosphatidylinositol 3-Kinases; Class Ib Phosphatidylinositol 3-Kinase; Furans; Mesenteric Arteries; Mice; Mice, Knockout; Morpholines; Neoplasms; Neovascularization, Pathologic; Phenylephrine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Pyrimidines; Pyrimidinones; Receptors, Adrenergic, alpha-1; Signal Transduction; Vasoconstriction; Wortmannin | 2016 |
[APROPOS OF THE REGULATION OF CELL DIVISION IN CANCEROUS TISSUES].
Topics: Animals; Cell Division; Epinephrine; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylephrine; Rats; Research; Sarcoma; Sarcoma, Experimental; Sympatholytics | 1963 |
Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Calcium Channel Blockers; Calcium Signaling; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; In Vitro Techniques; Male; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasms; Patch-Clamp Techniques; Phenylephrine; Piperazines; Rats; Rats, Sprague-Dawley; Siloxanes | 2008 |
Liminal therapy: a strategy for the complete and selective destruction of malignant tissue in situ.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dihydralazine; Drug Resistance; Energy Metabolism; Humans; Hydralazine; Isoproterenol; Mice; Naphazoline; Neoplasms; Oxygen; Oxygen Consumption; Phenylephrine; Sarcoma, Experimental; Time Factors; Vasopressins | 1984 |
Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma.
Topics: Animals; Axilla; Blood Circulation; Blood Pressure; Carcinoma; Cardiac Output; Humans; Hyperkinesis; Isoproterenol; Male; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Phenoxybenzamine; Phenylephrine; Propranolol; Rats; Regression Analysis | 1980 |
Modification of vascular tone using iNOS under the control of a radiation-inducible promoter.
Topics: Animals; Blotting, Western; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Endothelium, Vascular; Gene Expression; Genetic Therapy; Male; Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Phenylephrine; Promoter Regions, Genetic; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; X-Rays | 2000 |